Entrada Therapeutics annual debt-to-equity ratio
2021
2022
2023
2024
2025
Entrada Therapeutics Debt-to-Equity Ratio Growth & History (TRDA)
Entrada Therapeutics's debt-to-equity ratio was 0.17 for fiscal 2025.
View full Entrada Therapeutics company overviewEntrada Therapeutics annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.17 | 0.03 | +20.46% |
| 2024 | 2024-12-31 | 0.14 | −0.14 | −50.94% |
| 2023 | 2023-12-31 | 0.28 | 0.16 | +130.72% |
| 2022 | 2022-12-31 | 0.12 | 0.12 | — |
| 2021 | 2021-12-31 | 0.00 | — | — |
Entrada Therapeutics quarterly debt-to-equity ratio
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.21 | 0.06 | +44.18% |
| Q1 2026 | 2026-03-31 | 0.18 | 0.05 | +34.47% |
| Q4 2025 | 2025-12-31 | 0.17 | 0.03 | +20.46% |
| Q3 2025 | 2025-09-30 | 0.15 | 0.01 | +5.96% |
| Q2 2025 | 2025-06-30 | 0.14 | −0.01 | −3.77% |
| Q1 2025 | 2025-03-31 | 0.14 | −0.11 | −44.61% |
| Q4 2024 | 2024-12-31 | 0.14 | −0.14 | −50.94% |
| Q3 2024 | 2024-09-30 | 0.15 | −0.13 | −48.17% |
| Q2 2024 | 2024-06-30 | 0.15 | −0.20 | −57.53% |
| Q1 2024 | 2024-03-31 | 0.25 | 0.18 | +249.01% |
| Q4 2023 | 2023-12-31 | 0.28 | 0.16 | +130.72% |
| Q3 2023 | 2023-09-30 | 0.28 | 0.16 | +133.65% |
| Q2 2023 | 2023-06-30 | 0.35 | 0.24 | +202.11% |
| Q1 2023 | 2023-03-31 | 0.07 | −0.04 | −38.47% |
| Q4 2022 | 2022-12-31 | 0.12 | 0.12 | — |
| Q3 2022 | 2022-09-30 | 0.12 | — | — |
| Q2 2022 | 2022-06-30 | 0.12 | — | — |
| Q1 2022 | 2022-03-31 | 0.11 | — | — |
| Q4 2021 | 2021-12-31 | 0.00 | — | — |
Entrada Therapeutics debt-to-equity ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Entrada Therapeutics's debt-to-equity ratio increased from 0.00 to 0.17, a change of 0.17. The latest reported quarter, Q2 2026, shows 0.21.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Entrada Therapeutics source filings ↗